Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.
Overview
Weight Loss peptide therapy, in brief
Peptide therapy has become one of the most effective medical approaches to sustainable weight loss. GLP-1 receptor agonists like Semaglutide and Tirzepatide have demonstrated 15 to 20% body weight reduction in clinical trials, while compounded peptides like AOD-9604 target fat metabolism directly. With RFK Jr. moving to reclassify several peptides for legal compounding in 2026, access to these therapies is expanding rapidly.
+Appetite suppression and reduced cravings
+Targeted fat metabolism without muscle loss
+Improved insulin sensitivity and blood sugar control
+Sustainable long-term weight management
+Potential cardiovascular benefits (GLP-1s)
Mechanism
How weight loss peptides work
Weight loss peptides work through several distinct biological mechanisms. GLP-1 agonists (semaglutide, tirzepatide) mimic the incretin hormone GLP-1, which signals the brain's appetite centers to reduce hunger, slows gastric emptying so food stays in the stomach longer, and improves insulin sensitivity. Tirzepatide adds a second mechanism via GIP receptor activation, which enhances fat metabolism. AOD-9604 is a fragment of human growth hormone (amino acids 177 to 191) that stimulates lipolysis, the breakdown of stored fat, without the blood sugar or growth effects of full HGH. CJC-1295 + Ipamorelin stimulate natural growth hormone production, which shifts body composition toward lean mass over fat storage. Most patients start with a low dose and titrate up over 12 to 16 weeks to minimize GI side effects.
Evidence
What the studies show
14.9% average weight loss
STEP 1 Trial (N=1,961)
Semaglutide 2.4mg vs 2.4% placebo over 68 weeks
20.9% average weight loss
SURMOUNT-1 Trial (N=2,539)
Tirzepatide 15mg, with 36% of patients losing ≥25% body weight
20% reduction in cardiac events
SELECT Trial (N=17,604)
Semaglutide demonstrated cardiovascular benefit beyond weight loss
$147 to $475/mo compounded
Peptide Injections AI Data
vs $1,000 to $1,400/mo for brand-name Wegovy or Zepbound without insurance
Weight loss peptide therapy is typically prescribed for adults with a BMI ≥30 (obese) or BMI ≥27 with at least one weight-related condition (type 2 diabetes, hypertension, dyslipidemia). It's also used for patients who have failed to achieve meaningful results with diet and exercise alone, or who have regained weight after previous interventions. GLP-1 therapy is not recommended for patients with a history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or who are pregnant or breastfeeding.
Protocol
A typical weight loss protocol
A typical weight loss peptide protocol begins with a medical evaluation including baseline labs (HbA1c, lipid panel, thyroid, CMP). Semaglutide starts at 0.25mg/week and titrates to 2.4mg over 16 weeks. Tirzepatide follows a similar escalation from 2.5mg to 15mg. Most providers include monthly check-ins, lab monitoring at 12 weeks, and dietary guidance, particularly around protein intake (25 to 30g per meal) to preserve lean muscle mass during rapid weight loss. Compounded formulations are available as subcutaneous injections, sublingual drops, or oral tablets depending on the provider.
Reference only, not a prescription. Your clinician sets the plan.
How much weight can you lose with peptide therapy?
+
Clinical trials show GLP-1 agonists like Semaglutide can produce 15 to 20% body weight loss over 68 weeks. Individual results vary based on dosage, diet, exercise, and starting weight. Compounded peptides like AOD-9604 have less clinical data but are commonly reported to support 5 to 10% body weight reduction.
Are weight loss peptides safe?
+
FDA-approved GLP-1s (Semaglutide, Tirzepatide) have undergone rigorous clinical trials. Common side effects include nausea, constipation, and injection site reactions. Compounded peptides have less safety data. Always work with a licensed provider who monitors your health throughout treatment.
How much do weight loss peptides cost?
+
Compounded Semaglutide typically costs $200 to $500/month. Brand-name Wegovy or Zepbound can cost $1,000 to $1,500/month without insurance. AOD-9604 runs $100 to $250/month from compounding pharmacies.
Do I need a prescription for weight loss peptides?
+
Yes. All peptide therapies for weight loss require a prescription from a licensed healthcare provider. Many telehealth providers on our platform can evaluate you remotely and prescribe if appropriate.
What is the RFK peptide reclassification?
+
In 2026, HHS Secretary Robert F. Kennedy Jr. announced plans to reclassify 14 to 19 peptides previously banned from compounding pharmacies, including AOD-9604. This would make these peptides legally available through regulated compounding pharmacies for the first time since 2023.
Find a provider for weight loss
The 2-minute quiz matches you with licensed providers. A clinician decides what, if anything, fits.